🧠AI AnalysisErasca Advances ERAS-0015 Development Amid High Demand
Erasca is progressing with its pan-RAS molecular glue ERAS-0015, drawing strong interest as it prepares for a Phase 1 clinical update.
🧠AI AnalysisErasca is progressing with its pan-RAS molecular glue ERAS-0015, drawing strong interest as it prepares for a Phase 1 clinical update.
Got a tip, a proposal or a partnership question? Write to us and we will reply shortly.